• Adrian Simpson, United States says, "If you are looking for a fair deal on medical supplies, IDM is something I would seriously recommend. Am hooked for life."
  • Craig, United States says, "Seemed easy to purchase, reasonable prices. Good customer service when I used it."
  • Brian Pavey, United States says, "IDM makes online shopping a pleasure. Shopping is so simple that you just breeze through it."
  • Harry Mason, United States says, "I have to admit am a bit of a lazy bloke when it comes to ordering online .And IDM pampers me to the hit as it's so simple to order."
  • John Hanks, United States says, "I was a sceptic until my first order. After, I received my first package, I turned believer. Now, it’s been 3 years since I have been ordering from IDM."
  • Natalie Wallace, United States says, "I was apprehensive about how my doubts would be addressed but what the heck,I went ahead and placed my order. Customer service was patient and helped me out."
  • Mark Penning, United States says, "Happy I got my package just in time for my vacation. Needless to say, it made my holiday a wonderfully satisfying experience."
  • Ask our pharmacist, if you have any questions related to your medications
    Click to find International Shipping charges at our pharmacy.
    Shop & Earn @ InternationalDrugMart
    Easy and secure shopping @ InternationalDrugMart.com.
    Get your instant Coupon now!
    You can find the latest happening of our pharmacy
    Follow us on Twitter

      Orchid Chemicals completes business transfer to Hospira

      Posted AtEconomictimes.indiatimes.com

      CHENNAI: City-based drug maker Orchid Chemicals & Pharmaceuticals has completed the sale and transfer of its generic injectable finished dosage business to Hospira Healthcare India Pvt Ltd, a wholly owned subsidiary of Hospira Inc, US.

      Orchid Chemicals had signed a business transfer agreement with Hospira last December to sell its injectibles business, the manufacturing complex, research and development facility at Irungattukottai near here along with employees for $400 million.

      Hospira, which has a 50:50 joint venture with the Ahmedabad-based Zydus Cadilla to manufacture oncological drugs, found the Orchid plant an apt fit as it did not have a presence in that segment.

      What further attracted the US company is the regulatory approvals -- including one from USFDA (US Food and Drug Administration) -- Orchid had.

      Orchid Managing Director K Raghavendra Rao said Tuesday the completion of the deal would enable the company to achieve financial flexibililty.

      "In addition, through the strategic supply arrangement with Hospira, Orchid would be ensuring long-term contractual API (active pharmaceutical ingredients) revenue streams," he said.

      CB Rao, Orchid's deputy managing director, will head Hospira India as its managing director.

      April 07, 2010


      Share this Article!

    Back to top^